BDNF- and VEGF-Responsive Stimulus to an NGF Mimic Cyclic Peptide with Copper Ionophore Capability and Ctr1/CCS-Driven Signaling.

Neurotrophins are a family of growth factors that play a key role in the development and regulation of the functioning of the central nervous system. Their use as drugs is made difficult by their poor stability, cellular permeability, and side effects. Continuing our effort to use peptides that mimic the neurotrophic growth factor (NGF), the family model protein, and specifically the N-terminus of the protein, here we report on the spectroscopic characterization and resistance to hydrolysis of the 14-membered cyclic peptide reproducing the N-terminus sequence (SSSHPIFHRGEFSV (c-NGF(1-14)). Far-UV CD spectra and a computational study show that this peptide has a rigid conformation and left-handed chirality typical of polyproline II that favors its interaction with the D5 domain of the NGF receptor TrkA. c-NGF(1-14) is able to bind Cu2+ with good affinity; the resulting complexes have been characterized by potentiometric and spectroscopic measurements. Experiments on PC12 cells show that c-NGF(1-14) acts as an ionophore, influencing the degree and the localization of both the membrane transporter (Ctr1) and the copper intracellular transporter (CCS). c-NGF(1-14) induces PC12 differentiation, mimics the protein in TrkA phosphorylation, and activates the kinase cascade, inducing Erk1/2 phosphorylation. c-NGF(1-14) biological activities are enhanced when the peptide interacts with Cu2+ even with the submicromolar quantities present in the culture media as demonstrated by ICP-OES measurements. Finally, c-NGF(1-14) and Cu2+ concur to activate the cAMP response element-binding protein CREB that, in turn, induces the brain-derived neurotrophic factor (BDNF) and the vascular endothelial growth factor (VEGF) release.

[1]  L. Rossi,et al.  Copper-Dependent Kinases and Their Role in Cancer Inception, Progression and Metastasis , 2022, Biomolecules.

[2]  G. Vistoli,et al.  Computational Insights into the Sequence-Activity Relationships of the NGF(1–14) Peptide by Molecular Dynamics Simulations , 2022, Cells.

[3]  M. Soligo,et al.  Intranasal Delivery of Nerve Growth Factor in Neurodegenerative Diseases and Neurotrauma , 2021, Frontiers in Pharmacology.

[4]  R. Marmorstein,et al.  The copper chaperone CCS facilitates copper binding to MEK1/2 to promote kinase activation. , 2021, The Journal of biological chemistry.

[5]  M. Varano,et al.  Nerve Growth Factor-Based Therapy in Alzheimer’s Disease and Age-Related Macular Degeneration , 2021, Frontiers in Neuroscience.

[6]  A. Magrì,et al.  Peptides Derived from Angiogenin Regulate Cellular Copper Uptake , 2021, International journal of molecular sciences.

[7]  Suzanne Gascon,et al.  Peptides Derived from Growth Factors to Treat Alzheimer’s Disease , 2021, International journal of molecular sciences.

[8]  C. Satriano,et al.  Metal ion coordination in peptide fragments of neurotrophins: A crucial step for understanding the role and signaling of these proteins in the brain , 2021 .

[9]  He Huang,et al.  Elucidating Solution Structures of Cyclic Peptides Using Molecular Dynamics Simulations. , 2021, Chemical reviews.

[10]  T. Gudasheva,et al.  Low‐molecular mimetics of nerve growth factor and brain‐derived neurotrophic factor: Design and pharmacological properties , 2020, Medicinal research reviews.

[11]  Chen Zhao,et al.  Exploring the Extended Biological Functions of the Human Copper Chaperone of Superoxide Dismutase 1 , 2019, The Protein Journal.

[12]  C. Chang,et al.  Copper (II) Ions Activate Ligand-Independent Receptor Tyrosine Kinase (RTK) Signaling Pathway , 2019, BioMed research international.

[13]  I. Naletova,et al.  The Copper(II)-Assisted Connection between NGF and BDNF by Means of Nerve Growth Factor-Mimicking Short Peptides , 2019, Cells.

[14]  A. Cuello,et al.  The Brain NGF Metabolic Pathway in Health and in Alzheimer’s Pathology , 2019, Front. Neurosci..

[15]  M. Eriksdotter,et al.  Innovative Therapy for Alzheimer’s Disease-With Focus on Biodelivery of NGF , 2019, Front. Neurosci..

[16]  L. F. Aguilar,et al.  Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer's disease , 2017, Neurobiology of Disease.

[17]  C. Satriano,et al.  The Inorganic Side of NGF: Copper(II) and Zinc(II) Affect the NGF Mimicking Signaling of the N-Terminus Peptides Encompassing the Recognition Domain of TrkA Receptor , 2016, Front. Neurosci..

[18]  M. Lascombe,et al.  Biophysical Studies of the Induced Dimerization of Human VEGF Receptor 1 Binding Domain by Divalent Metals Competing with VEGF-A , 2016, PloS one.

[19]  E. Rizzarelli,et al.  Intracellular Bioinorganic Chemistry and Cross Talk Among Different -Omics. , 2016, Current Topics in Medicinal Chemistry.

[20]  Y. J. Kang,et al.  Featured Article: Effect of copper on nuclear translocation of copper chaperone for superoxide dismutase-1 , 2016, Experimental biology and medicine.

[21]  P. Povarnina,et al.  Dimeric dipeptide mimetics of the nerve growth factor Loop 4 and Loop 1 activate TRKA with different patterns of intracellular signal transduction , 2015, Journal of Biomedical Science.

[22]  Adriana Pietropaolo,et al.  A small linear peptide encompassing the NGF N-terminus partly mimics the biological activities of the entire neurotrophin in PC12 cells. , 2015, ACS chemical neuroscience.

[23]  P. Alifano,et al.  The Role of Rab Proteins in Neuronal Cells and in the Trafficking of Neurotrophin Receptors , 2014, Membranes.

[24]  Michelle L. Turski,et al.  Copper is required for oncogenic BRAF signaling and tumorigenesis , 2014, Nature.

[25]  K. Sawamoto,et al.  Vascular regulation of adult neurogenesis under physiological and pathological conditions , 2014, Front. Neurosci..

[26]  F. Longo,et al.  Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease , 2013, Nature Reviews Drug Discovery.

[27]  C. Ibáñez,et al.  Genetic dissection of neurotrophin signaling through the p75 neurotrophin receptor. , 2012, Cell reports.

[28]  L. Manni,et al.  Nerve growth factor: from the early discoveries to the potential clinical use , 2012, Journal of Translational Medicine.

[29]  S. Howell,et al.  Copper influx transporter 1 is required for FGF, PDGF and EGF-induced MAPK signaling. , 2012, Biochemical pharmacology.

[30]  Zhen Zhang,et al.  Copper Is Required for Cobalt-Induced Transcriptional Activity of Hypoxia-Inducible Factor-1 , 2012, Journal of Pharmacology and Experimental Therapeutics.

[31]  A. Magrì,et al.  Probing the copper(II) binding features of angiogenin. Similarities and differences between a N-terminus peptide fragment and the recombinant human protein. , 2012, Inorganic chemistry.

[32]  G. Arena,et al.  The inorganic perspective of nerve growth factor: interactions of Cu2+ and Zn2+ with the N-terminus fragment of nerve growth factor encompassing the recognition domain of the TrkA receptor. , 2011, Chemistry.

[33]  A. Magrì,et al.  Copper(II) complex formation with a linear peptide encompassing the putative cell binding site of angiogenin. , 2010, Dalton transactions.

[34]  Benjamin M. Bulheller,et al.  Ultraviolet spectroscopy of protein backbone transitions in aqueous solution: combined QM and MM simulations. , 2010, The journal of physical chemistry. B.

[35]  A. Rosenzweig,et al.  Structural biology of copper trafficking. , 2009, Chemical reviews.

[36]  Fei Ye,et al.  Copper Regulation of Hypoxia-Inducible Factor-1 Activity , 2009, Molecular Pharmacology.

[37]  M. Yaar,et al.  A cyclic peptide that binds p75NTR protects neurones from beta amyloid (1–40)‐induced cell death , 2007, Neuropathology and applied neurobiology.

[38]  G. Perini,et al.  Functional cooperation between TrkA and p75(NTR) accelerates neuronal differentiation by increased transcription of GAP-43 and p21(CIP/WAF) genes via ERK1/2 and AP-1 activities. , 2007, Experimental cell research.

[39]  M. Baron,et al.  Vertebrate Ctr1 coordinates morphogenesis and progenitor cell fate and regulates embryonic stem cell differentiation , 2007, Proceedings of the National Academy of Sciences.

[40]  L. Reichardt,et al.  Neurotrophin-regulated signalling pathways , 2006, Philosophical Transactions of the Royal Society B: Biological Sciences.

[41]  P. Carloni,et al.  Molecular simulation of the binding of nerve growth factor peptide mimics to the receptor tyrosine kinase A. , 2006, Biophysical journal.

[42]  U. Felbor,et al.  VEGF receptors on PC12 cells mediate transient activation of ERK1/2 and Akt: comparison of nerve growth factor and vascular endothelial growth factor , 2006, Journal of Negative Results in Biomedicine.

[43]  A. Cuello,et al.  Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Steven G Potkin,et al.  A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease , 2005, Nature Medicine.

[45]  U. Moens,et al.  What turns CREB on? , 2004, Cellular signalling.

[46]  M. Chao,et al.  Neurotrophins and their receptors: A convergence point for many signalling pathways , 2003, Nature Reviews Neuroscience.

[47]  Christian Wiesmann,et al.  Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor , 1999, Nature.

[48]  R. Casareno,et al.  The Copper Chaperone CCS Directly Interacts with Copper/Zinc Superoxide Dismutase* , 1998, The Journal of Biological Chemistry.

[49]  K. Neet,et al.  Characterization of Histidine Residues Essential for Receptor Binding and Activity of Nerve Growth Factor* , 1996, The Journal of Biological Chemistry.

[50]  M. Greenberg,et al.  Nerve growth factor activates a Ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB , 1994, Cell.

[51]  Tom L. Blundell,et al.  New protein fold revealed by a 2.3-Å resolution crystal structure of nerve growth factor , 1991, Nature.

[52]  K. Steimer,et al.  Cu,Zn superoxide dismutase is a peroxisomal enzyme in human fibroblasts and hepatoma cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[53]  V. Hamburger,et al.  A NERVE GROWTH-STIMULATING FACTOR ISOLATED FROM SARCOM AS 37 AND 180. , 1954, Proceedings of the National Academy of Sciences of the United States of America.

[54]  E. Rizzarelli,et al.  Neurodegeneration: Metallostasis and Proteostasis , 2011 .

[55]  C. Alberini,et al.  Transcription factors in long-term memory and synaptic plasticity. , 2009, Physiological reviews.

[56]  M. Sofroniew,et al.  Nerve growth factor signaling, neuroprotection, and neural repair. , 2001, Annual review of neuroscience.

[57]  E. Huang,et al.  Neurotrophins: roles in neuronal development and function. , 2001, Annual review of neuroscience.